相关期刊:《Chinese Journal of Integrative Medicine》《World Journal of Gastroenterology》《World Journal of Gastrointestinal Pharmacology and Therapeutics》《Gastroenterology Report》更多>>
supported by the Guangxi Key Research and Development Plan(GuiKe AB24010082);the First-class Discipline Innovation-driven Talent Program of Guangxi Medical University.
Hepatobiliary-pancreatic cancers mainly include hepatocellular carcinoma,biliary tract cancers,pancreatic ductal adenocarcinoma(PDAC),and colorectal liver metastases(CRLM)(1).Surgical resection is one of the curative ...
The recently published guidelines on screening,monitoring and treatment update previous guidelines published 25 years ago(1,2).This update is timely as much has happened in the interim.Cystic fibrosis(CF)modulator the...
Colorectal cancer remains one of the commonest and most lethal malignancies worldwide(1).Up to 80%of patients with colorectal cancer develop liver metastases(CRLM),which are the main factor limiting survival(1,2).Desp...
supported by grants from Instituto de Salud Carlos III cofounded by Fondo Europeo de Desarrollo Regional-FEDER[contract numbers:FIS 21_01248;PI18/00901,UMA18-FEDERJA-193].CIBERehd is funded by Instituto de Salud Carlos III(ISCIII).All authors are members of the COST ACTION“CA-17112”-Prospective European Drug-Induced Liver Injury Network,supported by COST(European Cooperation in Science and Technology).www.cost.eu.JMPB holds a Rio Hortega contract from ISCIII.
Drug-induced liver injury(DILI)is a term used to describe an unexpected liver reaction to drugs,but also to herbal products and dietary supplements(HDS).In the current therapeutic armamentarium,only a small number of ...
This study has received funding by Outstanding Youth supported by Medical Science and Technology Development Foundation Nanjing(JQX16022);Jiangsu Province Key Medical Young Talents,“13th Five-Year”Health Promotion Project of Jiangsu Province(QNRC2016041);The study was conducted in accordance with the Declaration of Helsinki(as revised in 2013);The study was approved by local institutional review board(No.2019AE01036);informed consent from patients was waived due to its retrospective nature。
Background:Prediction models for the histological grade of hepatocellular carcinoma(HCC)remain unsatisfactory.The purpose of this study is to develop preoperative models to predict histological grade of HCC based on g...
Interpretation of NCCN guidelines for hepatobiliary tumors V3 update in 2021(1).Hepatobiliary tumors are a general term for a large group of tumors,including liver cancer and biliary tract tumors.It is rare,highly agg...
A 64-year-old female was admitted to our department because of abdominal discomfort and recurrent fever for 1 month,she had attended her local hospital 10 days earlier,where the sign of fever was regarded as being due...
There has been a chronic lack of effective treatment for hepatobiliary malignancies,and overall survival of comprehensive therapy,including targeted chemotherapy,is still low(1,2).
In the current era of immunotherapy, the treatment of hepatobiliary cancers is rapidly evolving. The use of immunotherapeutic approaches, which include peptide-based vaccines, checkpoint inhibitors and antibodies, par...
Background: Patients with advanced hepatobiliary cancer (HBC) have a dismal prognosis and limited treatment options. Immunotherapy has been considered as a promising treatment, especially for cancers not amenable to s...